CA Stock MarketDetailed Quotes
ATE Antibe Therapeutics Inc
- 0.295
- 0.0000.00%
15min DelayMarket Closed Apr 10 09:30 ET
15.64MMarket Cap-842P/E (TTM)
0.000High0.000Low0Volume0.000Open0.295Pre Close0.00Turnover1.23052wk High0.00%Turnover Ratio53.01MShares0.15052wk Low-0.35EPS TTM15.10MFloat Cap8.900Historical HighLossP/E (Static)51.20MShs Float0.150Historical Low-0.37EPS LYR0.00%Amplitude--Dividend TTM0.60P/B1Lot Size--Div YieldTTM
Antibe Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.33%9.67M | 12.09%9.54M |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 1.33%9.67M | 12.09%9.54M |
| Cost of revenue | -0.32%5.97M | 16.63%5.99M | ||||||||
| Gross profit | 4.11%3.7M | 5.18%3.55M | ||||||||
| Operating expense | -1.42%4.6M | 5.45M | 6.28M | -19.52%20.55M | 3.58M | 4.66M | 8.50%25.53M | 11.88%23.53M | 33.64%21.03M | 56.75%15.74M |
| Selling and administrative expenses | -5.68%2.29M | --1.96M | --2.71M | -17.30%9.24M | --2.19M | --2.43M | 10.57%11.17M | -18.41%10.1M | 8.83%12.38M | 64.43%11.38M |
| -Selling and marketing expense | 20.90%81K | --96K | --147K | 59.13%331K | --56K | --67K | 80.87%208K | -96.95%115K | 7.13%3.77M | 4.13%3.52M |
| -General and administrative expense | -6.43%2.21M | --1.86M | --2.57M | -18.75%8.91M | --2.14M | --2.36M | 9.76%10.96M | 15.99%9.99M | 9.60%8.61M | 122.04%7.86M |
| Research and development costs | 3.23%2.3M | --3.49M | --3.57M | -21.24%11.31M | --1.39M | --2.23M | 6.93%14.36M | 66.24%13.43M | 104.84%8.08M | 43.78%3.94M |
| Depreciation amortization depletion | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 37.26%571K | 10.30%416K |
| -Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 37.26%571K | 10.30%416K |
| Operating profit | 1.42%-4.6M | -5.45M | -6.28M | 19.52%-20.55M | -3.58M | -4.66M | -8.50%-25.53M | -35.74%-23.53M | -42.24%-17.34M | -82.87%-12.19M |
| Net non-operating interest income (expenses) | -15.54%386K | 462K | 482K | 390.88%1.35M | 353K | 457K | 621.05%274K | 109.48%38K | -0.50%-401K | 65.62%-399K |
| Non-operating interest income | -15.47%388K | --464K | --484K | 379.79%1.35M | --354K | --459K | 513.04%282K | -53.54%46K | 219.35%99K | 78.71%31K |
| Non-operating interest expense | 0.00%2K | --2K | --2K | 0.00%8K | --1K | --2K | 0.00%8K | -98.40%8K | 16.28%500K | -63.50%430K |
| Other net income (expenses) | -3K | -19K | 12K | -1,900.00%-90K | -7K | 101.39%5K | 72.60%-360K | -1,283.16%-1.31M | -179.07%-95K | |
| Gain on sale of security | ---3K | ---19K | --12K | -1,900.00%-90K | ---7K | ---- | -94.57%5K | 396.77%92K | 67.37%-31K | -179.07%-95K |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 64.77%-452K | ---1.28M | --0 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.28M | --0 |
| -Less:Write off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --452K | --0 | ---- |
| Income before tax | -0.19%-4.21M | -5.01M | -5.79M | 23.60%-19.29M | -3.24M | -4.21M | -5.86%-25.25M | -25.21%-23.85M | -50.22%-19.05M | -64.59%-12.68M |
| Income tax | 0 | -99.26%1K | 149.13%135K | |||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 2.39%-4.21M | -5.01M | -5.79M | 22.29%-19.48M | -3.55M | -4.32M | 4.72%-25.06M | -35.97%-26.3M | -50.93%-19.34M | -72.49%-12.82M |
| Net income continuous operations | -0.19%-4.21M | ---5.01M | ---5.79M | 23.60%-19.29M | ---3.24M | ---4.21M | -5.86%-25.25M | -25.21%-23.85M | -48.65%-19.05M | -72.49%-12.82M |
| Net income discontinuous operations | --0 | --0 | --0 | -196.84%-184K | ---312K | ---111K | 107.76%190K | -738.36%-2.45M | ---292K | ---- |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 2.39%-4.21M | -5.01M | -5.79M | 22.29%-19.48M | -3.55M | -4.32M | 4.72%-25.06M | -35.97%-26.3M | -50.93%-19.34M | -72.49%-12.82M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 2.39%-4.21M | -5.01M | -5.79M | 22.29%-19.48M | -3.55M | -4.32M | 4.72%-25.06M | -35.97%-26.3M | -50.93%-19.34M | -72.49%-12.82M |
| Diluted earnings per share | 0.00%-0.08 | -0.1 | -0.11 | 26.00%-0.37 | -0.06 | -0.08 | 28.57%-0.5 | 1.41%-0.7 | -18.33%-0.71 | -20.00%-0.6 |
| Basic earnings per share | 0.00%-0.08 | -0.1 | -0.11 | 26.00%-0.37 | -0.06 | -0.08 | 28.57%-0.5 | 1.41%-0.7 | -18.33%-0.71 | -20.00%-0.6 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg